CLAIBORNE MEDICAL CENTER — History
CCN 440057 | 3-year financial timeline | COVID resilience: 35/100
🛡️ Public data only — no PHI permitted on this instance.
$31M
Latest Revenue (FY2022)
+0.9%
Revenue CAGR (3yr)
-9.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $30M | $34M | $31M | -7.7% | +0.9% |
| Operating Expenses | $33M | $34M | $34M | -0.7% | +1.4% |
| Operating Margin | -8.9% | -2.2% | -9.9% | -354.9% | +0.0% |
| Net Income | $-3M | $-1M | $-3M | -320.1% | +0.0% |
| Licensed Beds | 33 | 26 | 26 | +0.0% | -11.2% |
| Total Patient Days | 4,715 | 5,734 | 3,534 | -38.4% | -13.4% |
| Medicare Day % | 26% | 20% | 25% | +23.5% | -1.4% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 35/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: +1.9% ($30M → $31M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▶ Stable
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+0.9%
This Hospital
+7.6%
State Avg
Latest Margin
-9.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $31M | -10.4% |
| FY2024 (proj) | $32M | -10.8% |
| FY2025 (proj) | $32M | -11.3% |